DR Congo's Ebola outbreak declared global emergency as cases exceed 5,000

The World Health Organization has declared the Ebola outbreak in the Democratic Republic of the Congo a global health emergency, a designation that carries weight: the caseload has climbed past 5,000, and more than 2,320 people have died. This is now the deadliest Ebola outbreak in the country's recorded history, surpassing even the 2018-to-2020 epidemic that killed 2,299.

The declaration came after an emergency meeting on Tuesday, where WHO Director-General Tedros Adhanom Ghebreyesus made clear that the situation remains dire and uncontrolled. "We must be frank: The epidemic is far from being under control," he said. "It had a big head start, and we are still playing catch-up." The outbreak is the seventeenth to strike the DRC, but its scale and trajectory have set it apart. Tedros warned that the virus is spreading at an unprecedented speed, and crucially, health officials are still identifying new transmission chains that must be broken to halt its advance. The epidemic will persist, he cautioned, until every single chain is found and severed.

What makes this outbreak particularly difficult to contain is the nature of the virus itself. The strain circulating is called Bundibugyo, and it currently has no approved vaccine or treatment available. This absence of medical countermeasures forces responders to rely almost entirely on detection, isolation, and breaking transmission through behavioral change—a far harder task in a country already fractured by conflict and suspicion. The mineral-rich DRC is dealing with active armed conflict in affected areas, misinformation spreading faster than health messaging, and deep distrust of health workers rooted in historical and ongoing grievances. Cultural practices and traditions that bring families together during illness and death also create opportunities for the virus to spread.

The timeline reveals how far behind the response has been from the start. The outbreak was officially declared on May 17, but genetic analysis of virus samples shows that transmission actually began in February—three months of undetected spread before anyone sounded the alarm. By the time the world knew what was happening, the virus had already established itself across multiple communities and provinces.

Response teams are now getting creative in their approach to community engagement. Motorbike riders, who ferry patients and bodies across the landscape, have become a central focus. Rather than simply asking them to use hand-washing stations and disinfectant—resources that have been distributed—health officials are now recruiting these riders as surveillance and response officers. They are positioned to spot cases early, report them, and help enforce isolation measures. It is a recognition that stopping Ebola requires enlisting the people who move through communities, not just the formal health system.

There is a glimmer of hope on the horizon, though it remains conditional. An experimental vaccine developed by scientists at Oxford University has begun human trials. The first volunteer received an injection in the United Kingdom last month. Hundreds of thousands of doses have already been manufactured in India and are sitting ready for deployment—but only if the trials prove the vaccine is safe and effective. The speed of manufacturing and stockpiling suggests that if the vaccine works, it could be deployed rapidly. For now, though, the world is watching a virus that has already claimed more than 2,300 lives, continues to spread across six provinces, and shows no sign of slowing without intervention.